Hotung Capital Management

Hotung Capital Management is a venture capital firm that focuses on early-stage technology companies, primarily in the United States, Taiwan, China, Israel, and the United Kingdom. The firm specializes in sectors such as medical devices, biotechnology, healthcare, artificial intelligence, internet of things, cloud services, e-commerce, manufacturing, and agricultural innovations.

The firm's investment strategy involves providing capital to startups and expansion-stage companies, aiming to achieve capital appreciation through a diversified portfolio. Hotung Capital Management also offers consultancy and advisory services to entities within its group.

Over the years, Hotung Capital Management has invested in numerous companies, with a notable transaction on January 8, 2019, involving a $39 million investment in EarlySense. Other investments include ACT Genomics, Cnano Technology Limited, deCarta, WiSpry, Chelsio Communications, Power Analog Microelectronics, Vivace Semiconductor, and ZettaCom, among others. The firm's portfolio reflects its commitment to fostering innovation and supporting the growth of technology-driven enterprises.